Pantheon hands off Cinven stakes
The Fourth Cinven Fund raised €6.58bn in 2006 and exited allergy testing company Phadia for $3.52bn in 2011.
19 December 2014•2 mins read
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence- Curated insights to keep you ahead of GP-led and LP-led secondaries
- Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
- Access to proprietary research and reports
- Selected fund performance and investor activity data